|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
2U54CA163071-06
|
$1,427,230
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(PQ #10) Gut-brain interactions underlying chemotherapy-induced behavioral comorbidities
|
1R01CA216290-01
|
$338,903
|
PYTER, LEAH
|
OHIO STATE UNIVERSITY
|
|
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
|
1R01CA216265-01
|
$632,860
|
CHRISTENSEN, BROCK
|
DARTMOUTH COLLEGE
|
|
(PQ9) A NOVEL MECHANISM OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY AND POTENTIAL TREATMENT
|
7R01CA208765-02
|
$356,362
|
YANG, QING
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA203000-03
|
$1,192,293
|
SIMON, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-08
|
$919,471
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
2U54CA163068-06
|
$1,656,304
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-12
|
$407,680
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202995-03
|
$820,604
|
CIECIERSKI, CHRISTINA
|
NORTHEASTERN ILLINOIS UNIVERSITY
|
|
2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization
|
5R01CA194307-02
|
$548,690
|
EISENBREY, JOHN
|
THOMAS JEFFERSON UNIVERSITY
|
|
402 -- A PHASE I TRIAL OF THE SAFETY IMMUNOGENICITY OF RG1-VLP... (PROTOCOL UWI2016-08-02). CONTRACTOR: UNIVERSITY OF WISCONSIN. CONTRACT NO: HHSN261201200033I, TASK ORDER: HHSN261000012. FROM 9/1
|
261201200033I
|
$1,485,915
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
A biophysical approach to elucidating the molecular mechanisms of mitotic inhibitor targets
|
1F99CA223018-01
|
$32,868
|
MICKOLAJCZYK, KEITH
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
A Biopsychosocial Approach to Behavioral Oncology in Young Adults
|
1F99CA222727-01
|
$33,279
|
DARABOS, KATHLEEN
|
HUNTER COLLEGE
|
|
A cluster randomized trial of a primary palliative care intervention (CONNECT) for patients with advanced cancer
|
5R01CA197103-02
|
$587,798
|
SCHENKER, YAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$339,315
|
Barchi, Joseph
|
CCR (NCI)
|
|
A highly specific NIRF/PET probe for the detection of cancer and metastases
|
1R43CA210854-01A1
|
$224,958
|
Yang, Xinlin
|
IMOL RADIOPHARMACEUTICALS, LLC
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
5R01CA174851-04
|
$538,152
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
A microRNA mediating vascular directed fibrinolysis and tumor progression
|
7F31CA213793-02
|
$33,314
|
MCCANN, JAMES
|
UNIVERSITY OF VIRGINIA
|
|
A Naturalistic Nationwide Randomized Study of e-Cigarette Uptake and Consequences
|
1R01CA210625-01A1
|
$488,627
|
CARPENTER, MATTHEW
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC
|
ZIA BC 011786
|
$32,548
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
|
1R44CA221513-01
|
$1,017,478
|
DEVENPORT, MARTIN
|
ONCOIMMUNE, INC.
|
|
A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors
|
5R01CA200977-02
|
$639,856
|
GANZ, PATRICIA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Prospective Study of the Impact of Breast Cancer on Symptoms and Functioning
|
5R01CA199137-03
|
$392,439
|
AVIS, NANCY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$97,645
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A simple assay system for rapid detection of circulating tumor cells
|
3R41CA183428-01A1S2
|
$50,000
|
HONG, BIN
|
TELOVISION, LLC
|
|
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
|
5R21CA198237-02
|
$88,993
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S2
|
$55,717
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-42S3
|
$65,235
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Accountability for Cancer Care through Undoing Racism and Equity (ACCURE)
|
3R01CA150980-05S2
|
$149,065
|
ENG, EUGENIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,629,581
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
5U24CA180921-05
|
$705,863
|
BECICH, MICHAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Aerobic Capacity, Depression, & Inflammatory Responsivity in Cancer Survivors
|
5R01CA186251-03
|
$628,582
|
KIECOLT-GLASER, JANICE
|
OHIO STATE UNIVERSITY
|
|
Affective Consequences of Chemotherapy
|
5R01CA194924-03
|
$401,389
|
DEVRIES, ANNE
|
OHIO STATE UNIVERSITY
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
AMPATH-Oncology Institute: HPV and Cervical Cancer in Kenyan Women with HIV/AIDS
|
5U54CA190151-04
|
$597,127
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
An Imaging Technology for Intra-Operative Surgical margin assessment in oral and Head and Neck Cancers (OSCC)
|
1R01CA220663-01A1
|
$511,569
|
ST JOHN, MAIE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
An organotypic model recapitulating colon cancer microenvironment and metastasis
|
1U01CA214300-01A1
|
$560,162
|
HUANG, EMINA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Analyzing Complex Cancer Studies With Skewed Responses
|
5R03CA205018-02
|
$83,299
|
LIPSITZ, STUART
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
Barr, Frederic
|
CCR (NCI)
|
|
Annual anal sampling using DNA screening to identify men who have sex with men at increased risk for anal cancer
|
1R01CA215403-01A1
|
$380,613
|
NYITRAY, ALAN
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|